Gainers

  • Soleno Therapeutics, Inc. SLNO shares jumped 318.5% to $18.54 after the company released top-line results from randomized withdrawal period of study C602 of DCCR for Prader-Willi Syndrome.
  • Femasys Inc. FEMY surged 244% to $1.1410 after the company received FDA 510(k) clearance for FemaSeed, an infertility treatment designed to deliver sperm directly to where conception occurs in a woman's fallopian tube.
  • Intercept Pharmaceuticals, Inc. ICPT shares gained 77.3% to $18.50. Alfasigma agreed to acquire Intercept Pharmaceuticals for $19.00 per share in cash.
  • Immunovant, Inc. IMVT jumped 75.6% to $35.60 after the company announced initial IMVT-1402 Phase 1 SAD and 300 mg subcutaneous MAD results.
  • Tharimmune Inc THAR shares gained 39.5% to $0.3090 after falling around 5% on Monday.
  • Acasti Pharma Inc. ACST gained 27.1% to $2.2250. Acasti announced a $7.5 million private placement equity financing.
  • Cano Health, Inc. CANO surged 24.2% to $0.3380. Cano Health said it sold substantially all of the assets associated with the operation of Cano Health's senior-focused primary care centers in Texas and Nevada to CenterWell Senior Primary Care.
  • Bullfrog AI Holdings, Inc. BFRG gained 23.6% to $3.5499. Bullfrog AI announced data from its preclinical study investigating the anti-cancer activity of a novel prodrug of mebendazole for glioblastoma.
  • Avalo Therapeutics, Inc. AVTX gained 21.9% to $0.1987 after jumping over 36% on Monday. Avalo Therapeutics reported the payoff of the remainder of its $35 million debt owed to Horizon Technology Finance.
  • Adaptive Biotechnologies Corporation ADPT shares climbed 21.2% to $6.16. Adaptive recently announced the launch of Epic integration for clonoSEQ.
  • Infobird Co., Ltd IFBD shares gained 19.7% to $0.1561. Infobird recently announced receipt of delinquency notification letter from the Nasdaq.
  • ARS Pharmaceuticals, Inc. SPRY gained 18.8% to $4.28 after Director Rajeev Shah acquired a total of 2,700,000 shares an average price of $3.03 for roughly $8.18 million.
  • Roivant Sciences Ltd. ROIV gained 17% to $11.94 after the company announced initial IMVT-1402 Phase 1 SAD and 300 mg subcutaneous MAD results.
  • Verve Therapeutics, Inc. VERV rose 16.6% to $13.25. Verve Therapeutics to unveil interim data on VERVE-101 at the American Heart Association's Event.
  • Pliant Therapeutics, Inc. PLRX gained 15% to $16.77 after the company announced bexotegrast met its primary and secondary endpoints in the Phase 2a liver fibrosis trial.
  • Fisker Inc. FSR rose 14.2% to $6.06 after the company announced that deliveries are set to ramp up.
  • Planet Green Holdings Corp. PLAG surged 14.1% to $0.6470.
  • BYND Cannasoft Enterprises Inc. BCAN rose 13.2% to $1.01.
  • Adaptive Biotechnologies Corporation ADPT gained 12.4% to $5.71.
  • Acutus Medical, Inc. AFIB jumped 11.7% to $0.6601.
  • Aclarion, Inc. ACON gained 11.4% to $0.39.
  • Vera Therapeutics, Inc. VERA climbed 10.3% to $15.69 as HC Wainwright & Co maintained a Buy rating on the stock and raised its price target from $10 to $25.
  • Blue Star Foods Corp. BSFC rose 8.6% to $0.2520 after dipping 20% on Monday.
  • NightHawk Biosciences, Inc. NHWK gained 7.5% to $0.57.
  • Precigen, Inc. PGEN rose 7.4% to $1.44.

Losers

  • TransCode Therapeutics, Inc. RNAZ shares fell 68.7% to $0.7990 after the company priced its $8 million public offering of 15.7 million shares at $0.51 per share.
  • Murphy Canyon Acquisition Corp. CDT fell 35.7% to $6.67 after dipping 38% on Monday.
  • Davis Commodities Limited DTCK declined 33.2% to $3.15. The company recently priced its IPO at $4 per share.
  • Molekule Group, Inc. MKUL fell 28.8% to $0.2064.
  • Polished.com Inc. POL fell 25.2% to $0.0928 after surging 40% on Monday.
  • United Natural Foods, Inc. UNFI fell 23.3% to $14.51 after the company reported mixed fourth-quarter financial results and issued guidance.
  • MicroAlgo Inc. MLGO fell 19.2% to $2.43.
  • Genetron Holdings Limited GTH fell 18.2% to $0.7201.
  • Greenfire Resources Ltd. GFR declined 16.4% to $6.52.
  • Novo Integrated Sciences, Inc. NVOS fell 14.9% to $0.2261.
  • Ebix, Inc. EBIX dipped 12.8% to $10.36.
  • New Pacific Metals Corp. NEWP declined 12.2% to $1.9487. New Pacific Metals announced CAD$35 million bought deal financing.
  • Greenfire Resources Ltd. GFR fell 11.5% to $6.90.
  • Biophytis S.A. BPTS fell 11.2% to $1.4099. Biophytis shares jumped over 72% on Monday after the company and Skyepharma announced a partnership agreement for the production of regulatory batches of Sarconeos (BIO101) for severe forms of Covid-19.
  • Roadzen, Inc. RDZN fell 10.3% to $4.8135.
  • Akili, Inc. AKLI declined 9.4% to $0.5130.
  • FaZe Holdings Inc. FAZE shares fell 8.9% to $0.1749 after jumping 25% on Monday.
  • MSP Recovery, Inc. LIFW shares fell 7.8% to $0.1867 after declining around 15% on Monday.
  • TROOPS, Inc. TROO fell 6.4% to $3.8199.
  • Sacks Parente Golf, Inc. SPGC fell 6.3% to $1.2750. The company recently posted a narrower second-quarter loss.
  • TD SYNNEX Corporation SNX fell 5.2% to $96.64. TD Synnex reported a third-quarter revenue decline of 9.1% Y/Y to $13.96 billion, missing the consensus of $14.11 billion.

Now Read This: Ethereum Rises But Remains Below This Key Level; Maker Emerges As Top Gainer

Market News and Data brought to you by Benzinga APIs

Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!